The largest database of trusted experimental protocols

Anti cd3 pacific blue and anti cd4 percp antibody

Manufactured by BioLegend
Sourced in United States

The Anti-CD3-Pacific Blue and Anti-CD4-PerCP antibodies are fluorochrome-conjugated monoclonal antibodies designed for the identification and enumeration of T lymphocyte subsets in flow cytometry applications.

Automatically generated - may contain errors

Lab products found in correlation

2 protocols using anti cd3 pacific blue and anti cd4 percp antibody

1

HLA Class II Tetramer Production and Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
HLA class II tetramers were produced as previously described[41] (link). Briefly, recombinant HLA-DR α- and β-chains were folded in the presence of a C-terminally hexahistidine(H6)-tagged version of the peptide in question. The peptide-HLA class II complexes were subsequently purified on a Ni2+ charged iminodiacetic acid column. The resulting monomers were tetramerized with PE- or APC-conjugated Streptavidin as described for the HLA class I tetramer above. In vitro cultured PBMCs were incubated with PE- and APC-conjugated HLA class II tetramers for 1 h at 37°C, 5% CO2. The cells were washed and subsequently stained with anti-CD3-Pacific blue and anti-CD4-PerCP antibody (Biolegend, San Diego, USA) for 30 min. All tetramer-stained cells were analyzed by flow cytometry on LSRII (BD Biosciences).
+ Open protocol
+ Expand
2

Characterizing Antigen-Specific T Cell Responses

Check if the same lab product or an alternative is used in the 5 most similar protocols
HLA class II tetramers were produced as previously described. Briefly, recombinant α- and β-chains (HLA-DRA1 and DRB5*01:01) were folded in the presence of either the wild-type IE1211-225 peptide, P3 variant, or P7 variant of the wild-type peptide. The resulting monomers were tetramerized with PE- or APC-conjugated streptavidin.
PBMC's from a donor previously determined to recognize the DRB5*01:01 restricted CMV IE1211–225 epitope (Braendstrup et al. 2014 (link)) was expanded on this epitope. The cells were double-stained with PE-labeled wild-type IE1211–225 -DRB5*01:01 tetramer and APC-labeled mutant peptide-DRB5*01:01 tetramer as previously described (Braendstrup et al. 2013 (link)). The cells were washed and subsequently stained with anti-CD3-Pacific blue and anti-CD4-PerCP antibody (Biolegend, San Diego, USA) for 30 min. The stained cells were analyzed by flow cytometry on a Fortessa (BD Biosciences).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!